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Acylaminoacyl peptidase (AAP) is an oligopeptidase that only cleaves short
peptides or protein segments. In the case of AAP from Aeropyrum pernix
(ApAAP), previous studies have led to a model in which the clamshell-like
opening and closing of the enzyme provides the means of substrate-size
selection. The closed form of the enzyme is catalytically active, while opening
deactivates the catalytic triad. The crystallographic results presented here show
that the open form of ApAAP is indeed functionally disabled. The obtained
crystal structures also reveal that the closed form is penetrable to small ligands:
inhibitor added to the pre-formed crystal was able to reach the active site of the
rigidified protein, which is only possible through the narrow channel of the
propeller domain. Molecular-dynamics simulations investigating the structure of
the complexes formed with longer peptide substrates showed that their binding
within the large crevice of the closed form of ApAAP leaves the enzyme
structure unperturbed; however, their accessing the binding site seems more
probable when assisted by opening of the enzyme. Thus, the open form of
ApAAP corresponds to a scavenger of possible substrates, the actual cleavage of
which only takes place if the enzyme is able to re-close.
1. Introduction
Acylaminoacyl peptidase [AAP; also called acylpeptide
hydrolase (APEH)] is a member of the prolyl oligopeptidase
protein family, which consists of serine protease enzymes
that impose size selection on their substrates, cleaving only
relatively short, unstructured peptides or protein segments
(Polga´r, 2002). Mammalian AAP is specifically able to remove
N-terminal acetylated amino acids from peptides, but is also
able to hydrolyze longer peptide chains. This lends the enzyme
its physiological significance: AAP has been shown to exert
regulation of protein maturation and degradation processes
(Perrier et al., 2005; Arnesen, 2011; Forte et al., 2011; Sando-
menico et al., 2012) and cell survival (Fujino et al., 2000;
Shimizu et al., 2003; Adibekian et al., 2011), most probably
through being an upstream modulator of the proteosome
(Shimizu et al., 2004; Palmieri et al., 2011). It has also even
been shown to be able to degrade multimeric forms of the
amyloid -peptide present in the Alzheimers brain (Yamin et
al., 2009).
Since the crystal structure of mammalian AAP has not yet
been determined, structural considerations must rely on the
structures of two archaeal analogues: AAP from Pyrococcus
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horikoshii (PhAAP) and Aeropyrum pernix (ApAAP)
(Bartlam et al., 2004; Menyha´rd et al., 2013). All oligopepti-
dases share a common modular structure, being composed of
a hydrolase and a propeller domain. The hydrolase domain
contains the Ser–His–Asp amino acids of the catalytic triad,
while the propeller domain provides the means of size selec-
tion, shielding the active site from the exterior. Between the
two, a spacious substrate-binding cavity can be found, which
can be accessed by one of the following pathways: (i) through
a narrow channel in the propeller domain, (ii) via a side gate
(Rasmussen et al., 2003; Engel et al., 2003; Menyha´rd et al.,
2013) or (iii) by the opening of the enzyme, as indicated by
different X-ray structures, molecular-dynamics and enzyme-
kinetic studies (Szeltner et al., 2004; Fuxreiter et al., 2005; Shan
et al., 2005; Li et al., 2010; Kaszuba et al., 2012; Canning et al.,
2013; Fig. 1). It is evident that if reaching the active site is an
elaborate process (such as passage through a long, narrow
passage, as in the first case; Fig. 1a) then enzyme efficiency is in
danger; on the other hand, if ready access is provided to the
active site (such as in the latter two cases, Figs. 1b and 1c) then
the exclusion of larger substrates, and thus selectivity, is hard
to maintain. Different oligopeptidases adopt different strate-
gies for simultaneous management of both size selection and
access to the active site. They also assume different multi-
merization states: prolyl oligopeptidase (PREP) and certain
forms of oligopeptidase B are monomeric (Fu¨lo¨p et al., 1998;
McLuskey et al., 2010), ApAAP, DPP-IV and oligopeptidase
B from other sources form dimers (Bartlam et al., 2004;
Rasmussen et al., 2003; Canning et al., 2013) and the active
form of PhAAP is a hexamer (Szeltner et al., 2009), while
mammalian AAP is tetrameric (Mitta et al., 1989).
In the case of ApAAP, previous studies revealed that the
monomers of the ApAAP dimer can adopt an open or a closed
conformation independently of one another. The active-site
conformation is distorted in the open state, which led us to
propose a model in which a clamshell-like opening of the
enzyme provides the means of approach (especially for larger
ligands), while this same movement simultaneously deacti-
vates the catalytic triad through the loss of interdomain
contacts (Harmat et al., 2011). The crystallographic and
simulation results presented here show that the open form of
ApAAP is indeed functionally disabled and indicate that
ApAAP provides different entrance mechanisms for
substrates of differing lengths and structural complexities:
substrates that are small enough to pass through the propeller
channel may directly approach the fully functional active site
of the closed form, while bulkier candidates may ligate to the
catalytically impaired but approachable active site of the open
form, where their compliance with the closure of the enzyme
will provide the means of size selection.
2. Materials and methods
2.1. Crystallization of ApAAP–CMK complexes
ApAAP was prepared and purified for crystallization as
described in Kiss et al. (2007). Previously published crystal-
lization conditions of ApAAP open/closed crystal forms were
optimized to obtain crystals of ApAAP with its covalent
chloromethyl ketone inhibitor (benzyloxycarbonyl-glycyl-
glycyl-phenylalanyl-chloromethyl ketone; CMK). The crystals
were grown at 293 K using the hanging-drop vapour-diffusion
method. Crystal 1 was grown in a drop obtained by mixing 3 ml
protein solution (221 mM ApAAP and 560 mM CMK in
20 mM Tris pH 7.5 buffer) and 3 ml reservoir solution [78 mM
sodium acetate buffer pH 4.5, 2.4%(w/v) PEG 4000, 6.7 mM
dithiothreitol, 0.44 mM EDTA]. The crystal was cryoprotected
in a solution with a similar composition to that of the reservoir
condition but also containing 23%(v/v) 2-methyl-2,4-pentane-
diol. Crystal 2 was grown in a drop obtained by mixing 3 ml
protein solution (158 mM ApAAP in 20 mM Tris pH 7.5
buffer) and 3 ml reservoir solution [78 mM sodium acetate
buffer pH 5.0, 2.2%(w/v) PEG 4000, 5.2 mM dithiothreitol,
0.34 mM EDTA]. Crystal 2 was soaked in reservoir condition
containing 1.58 mM CMK overnight, cryoprotected in
perfluoropolyether oil (MiTeGen LV CryoOil) and flash-
cooled in liquid nitrogen.
2.2. Data collection, processing and refinement of crystal
structures
All diffraction data were collected at 100 K. A data set was
collected from crystal 1 on a home diffractometer (Rigaku
RU200 generator, blue optics, R-AXIS IV++ detector; wave-
length 1.5418 A˚, ’ range of 100.5 with an increment of 0.5;
crystal-to-detector distance 100.03 mm). The data set from
research papers
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Figure 1
Schematic models of oligopeptidase monomers. The hydrolase domain
with the catalytic triad is shown in cyan, while the propeller domain is
coloured green. (a) The closed form found in structures of both the
ligand-free and the ligand-bound states of prolyl oligopeptidases from
various organisms (for examples, see Fu¨lo¨p et al., 1998, 2001; Szeltner,
Rea, Juha´sz et al., 2002; Szeltner, Rea, Renner et al., 2002; Shan et al.,
2005; Li et al., 2010), oligopeptidase B (McLuskey et al., 2010; Canning et
al., 2013), puromycin hydrolase (Matoba et al., 2011) and AAP from A.
pernix (Bartlam et al., 2004; Kiss et al., 2007, 2008; Harmat et al., 2011).
The catalytic triad is only accessible through the propeller channel. (b) A
monomer with a permanent side entrance as found in DPP-IV (for
examples, see Rasmussen et al., 2003; Engel et al., 2003; Thoma et al., 2003;
Nordhoff et al., 2006; Nakajima et al., 2008), tripeptidyl aminopeptidase
(Ito et al., 2006) and AAP from P. horikoshii (Menyha´rd et al., 2013).
These enzymes are active in multimer forms, and the permanent entry is
shielded by the other interacting monomers. (c) The open form seen in
the case of certain bacterial prolyl oligopeptidases (Shan et al., 2005; Li et
al., 2010), oligopeptidase B (Canning et al., 2013) and AAP from A.
pernix (Harmat et al., 2011).
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crystal 2 was collected on beamline ID14-1 at the European
Synchrotron Radiation Facility (ESRF; wavelength 0.9334 A˚,
’ range of 200.0 with an increment of 0.5; crystal-to-detector
distance 298.55 mm). The data sets were processed to 1.90 and
2.55 A˚ resolution for crystal 1 and crystal 2, respectively, using
the XDS and XSCALE programs (Kabsch, 2010.). The data-
collection statistics are summarized in Table 1. Note that the
data set from crystal 2 has low completeness in the 2.8–2.55 A˚
resolution range (Supplementary Table S1), but these data
were also used in refinement as a slight improvement in map
quality (Supplementary Fig. S1) and R factors could be
achieved (at the early stage of refinement paired refinement to
2.8 and 2.55 A˚ resolution resulted in a decrease in R and Rfree
of 0.002 and 0.005, respectively).
The structures were solved using the
difference Fourier method with the
CCP4 package (Winn et al., 2011) using
the protein atoms of the isostructural
structures with PDB entries 2hu5 (Kiss
et al., 2007; resolution 2.0 A˚) and 3o4h
(Harmat et al., 2011; resolution 1.8 A˚),
respectively. 5.0% of the reflections for
a test set for monitoring the refinement
process were imported from the data
sets of the isostructural model struc-
tures. The models were refined by
likelihood-based refinement using
REFMAC v.5.7.032 (Murshudov et al.,
2011), in which TLS refinement (Winn
et al., 2001) was carried out for
quaternary-structure regions (one TLS
group per domain for crystal 1 and one
TSL group per protein monomer for
crystal 2) and noncrystallographic
restraints were introduced for regions
with similar conformations in each
monomer. Model building was carried
out with Coot (Emsley et al., 2010) using
graphical comparison of noncrystallo-
graphically related monomers (NCS
ghost control option). Water molecules
were added to the model using the
water-picking mode of Coot (within
hydrogen-bonding distances of
hydrogen-bond donor or acceptor
atoms, with mFo  DFc density of
greater than 3.0 and checked for
refined B factors of less than 80 A˚2).
For crystal 1 the asymmetric unit
contains one ApAAP dimer, with both
molecules in the closed conformation
with convalently bound CMK inhibitors
in their active sites, 669 water molecules,
three 2-methyl-2,4-pentanediol mole-
cules, one acetate ion and one chloride
ion. 19 residues and seven water mole-
cules are modelled in alternate confor-
mations/positions. For crystal 2 the asymmetric unit contains
two ApAAP dimers with one of the monomers in the open
conformation and the other in the closed conformation, two
CMK inhibitors covalently bound to the two closed mono-
mers, 679 water molecules and six chloride ions. 15 residues
were modelled in alternate conformations: serines and a valine
with electron density between the two rotamers and longer
side chains with clear electron density for both rotamers (at
the 1.2 contour level of 2mFo  DFc density). Refinement
statistics and model quality are compiled in Table 1. The
coordinates and structure factors have been deposited in the
Protein Data Bank as entries 4re5 and 4re6, respectively. The
quality of the final structures was validated using MolProbity
(Chen et al., 2010). The r.m.s. fit of backbone atoms of crystal
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Table 1
Crystallographic data-collection and refinement statistics.
Values in parentheses are for the outer shell.
Crystal 1 2
Global conformation of the AAP
monomers within the dimer
Closed/closed Open/closed
PDB entry 4re5 4re6
Data-collection statistics
Diffraction source Rigaku RU200 rotating anode ESRF beamline ID14-1
Wavelength (A˚) 1.5418 0.9334
Detector Rigaku R-AXIS IV++ image plate ADSC Quantum 210 CCD
Space group P212121 P1
Unit-cell parameters
a (A˚) 63.81 71.58
b (A˚) 104.43 97.30
c (A˚) 170.08 99.16
 () 90 105.15
 () 90 103.96
 () 90 100.26
Resolution range (A˚) 20.0–1.90 (1.95–1.90) 20.0–2.55 (2.62–2.55)
Total No. of reflections 354000 (25117) 149085 (6410)
No. of unique reflections 90022 (6591) 68281 (2964)
Completeness (%) 99.7 (99.9) 86.4 (51.1)
Multiplicity 3.93 (3.81) 2.18 (2.16)
hI/(I)i 17.58 (2.27) 13.38 (2.16)
Rr.i.m. 0.062 (0.682) 0.071 (0.505)
CC1/2 0.999 (0.750) 0.997 (0.775)




No. of reflections, working set 85520 (6271) 64833 (2782)
No. of reflections, test set 4499 (315) 3441 (126)
Final Rwork 0.177 (0.294) 0.212 (0.285)
Final Rfree 0.218 (0.352) 0.260 (0.350)





R.m.s.d. from ideal geometry
Bonds (A˚) 0.016 0.011
Angles () 1.720 1.470






Most favoured (%) 97.1 96.9
Allowed (%) 2.9 3.1
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structures was calculated within the CCP4 package (Winn et
al., 2011). Figures were prepared using PyMOL v.0.99
(http://www.pymol.org) and Maestro from the Schro¨dinger
package.
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Figure 2
Crystal structures of the ApAAP–chloromethyl ketone complex. (a) Overall conformation of the closed/closed ApAAP dimer (cyan and green, with the
propeller domains in darker colours) with the bound inhibitor (orange). (b) The bound inhibitors in the active sites shown with 2mFo  DFc electron
density contoured at 1.2. (c) One of the two ApAAP dimers of the open/closed structure shown with the inhibitor bound only at the active site of the
closed monomer. (d, e) The bound inhibitors in the active sites of the closed monomers (d) and the empty active sites of the open monomers (e) of the
open/closed structure shown with 2mFo  DFc electron density contoured at 1.2. ( f ) Comparison of the conformations of the bound CMK inhibitors
(orange tones) with the hydrolase domains shown in cyan and the propeller domain shown in green (stereoview). The structure of the ApAAP–gylcyl-
phenylalanine enzyme–product-type complex (PDB entry 2hu5) is shown in grey for reference. Residues of the catalytic triad (Ser445, His556 and
Asp524) as well as Arg526 are labelled.
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2.3. Monte Carlo multiple minimum docking of substrates
10 000-step Monte Carlo multiple minimum (MCMM)
searches (Chang et al., 1989), as implemented in MacroModel
(v.10.2; Schro¨dinger), were carried out involving the random
variation (within the range 0–180) of a randomly selected
subset of all internal torsional angles of the substrates and a
random rigid-body translation (0–5 A˚) and rotation (0–180)
step of the substrate with respect to the enzyme within the
fixed interior of the enzyme in the Monte Carlo step. The
perturbed structures were energy-minimized allowing atoms
of the substrate to move freely, while applying a
200 kJ mol1 A˚2 restraint to side chains of the propeller
domain and freezing the rest of ApAAP. Unique structures
were stored within a 21 kJ mol1 energy window above the
global minimum. Calculations were carried out using the
AMBER force field (Cornell et al., 1995). The solvent effect
was modelled by the GB/SA algorithm (using water as the
solvent).
2.4. Molecular-dynamics simulations
TheMCMM-derived structures were subjected to molecular-
dynamics (MD) simulations as implemented in GROMACS
(Hess et al., 2008) using the CHARMM27 force field
(MacKerell et al., 2004; Bjelkmar et al., 2010). Systems were
solvated by approximately 17 000 TIP3P water molecules, the
total charge of the system was neutralized and a physiological
salt concentration (0.15M) was set using Na+ and Cl ions.
Conjugate-gradient energy minimization of starting structures
was followed by sequential relaxation of constraints on
protein atoms in three steps and an additional NVT step (all
of 200 ps) to stabilize the pressure. Trajectories of 200 ns
NPT simulations [where heavy-atom hydrogen bonds were
constrained using the LINCS algorithm (Hess, 2008) but no
other geometrical restraints were applied] at 300 K and 1 bar
[applying the velocity-rescale algorithm (Bussi et al., 2007)
and a Berendsen barostat] were recorded for further analysis
(collecting snapshots every 4 ps). Average structures for the
last 100 ns were calculated and used for comparison of models
and B-factor analysis. For figures, the snapshot with the lowest
backbone root-mean-square deviation (r.m.s.d.) compared
with the average structure was selected and energy-minimized.
Clustering of conformations (Daura et al., 1999) was carried
out using a cutoff of 0.8 A˚. Principal component analysis of
backbone motions was also carried out as implemented in
GROMACS.
2.5. Channel systems
Channels between the active site and the solvent were
calculated using MolAxis (Yaffe et al., 2008). The bottleneck
radius for PREP was measured and averaged in the following
characteristic crystal structures: PDB entries 1qfm (Fu¨lo¨p et
al., 1998) and 1h2w (Szeltner et al., 2002a). For ApAAP, values
obtained for PDB entries 2hu5, 2hu7, 2hu8 (Kiss et al., 2007),
1ve6, 1ve7 (Bartlam et al., 2004), 3o4g (Harmat et al., 2011)
and the four copies of the closed form determined in this study
were averaged. In the case of the MD-derived structures,
conformers of the 100–200 ns time range were clustered based
on the conformation of the residues defining the three chan-
nels considered (propeller channel, residues 23–43, 64–72,
111–121, 153–161, 194–204, 246–257 and 283–293; channel by
loopA, 82–89, 111–116, 129–134, 468–490, 520–529 and 551–
560; channel by the His-loop, 42–46, 58–64, 83–90 and 551–
560); the bottleneck radius was measured in the mid-structure
of each cluster and weighted by the occupancy of that cluster.
3. Results
3.1. Crystal structures of ApAAP–CMK complexes
3.1.1. Crystals with the open and closed enzyme form, and
the overall conformation of ApAAP. Previously determined
ApAAP structures contain dimers composed of closed/closed,
open/closed or open/open monomer pairs. Of these, the open/
closed dimer of ApAAP provides a unique structural model
system for the study of ApAAP, since this arrangement allows
the simultaneous testing of various effects on two different
conformations of the enzyme under identical experimental
conditions. Thus, it was our goal to crystallize the open/closed
dimer structure of ApAAP in complex with a substrate-like
inhibitor in order to determine the structural roles of domain
closure and substrate binding on reconstructing the active site.
The covalently binding inhibitor benzyloxycarbonyl-glycyl-
glycyl-phenylalanyl-chloromethyl ketone (CMK) was chosen
as our probe because (i) the initial chemical step of its binding
is similar to that of the enzymatic hydrolysis reaction catalyzed
by the enzyme and requires the residues of the catalytic
apparatus in active conformations (reviewed in Powers et al.,
2002) and (ii) the structure of the covalent complex highly
resembles that of an enzyme–substrate complex with minimal
shift of the serine and histidine side chains; thus, it is suitable
for studying enzyme–substrate contacts.
Two different crystal structures were determined. Our first
attempt to produce crystals of open/closed dimers was as
follows: the ApAAP–CMK complex was formed in solution
and then crystallized using the crystallization conditions of the
open/closed crystal form. Surprisingly, crystals of a different,
previously encountered crystal form (Bartlam et al., 2004; Kiss
et al., 2007) were obtained containing enzyme dimers in only
the closed conformation (closed/closed form; Fig. 2a), albeit
in this case of the CMK inhibitor-bound form (Fig. 2b). This
supports the hypothesis that ligand binding stabilizes the
closed form of ApAAP (Li et al., 2010; Harmat et al., 2011).
The enzyme backbone could be fitted to previously deter-
mined crystal structures with r.m.s.d. values of 0.29–0.56 A˚ for
all backbone atoms, indicating that no significant rearrange-
ment is required for ligand coordination.
We were successful in attaining the inhibitor-bound form of
the open/closed dimer structure by soaking pre-formed crys-
tals of the open/closed crystal form of the unligated enzyme in
a solution of CMK (Fig. 2c). The enzyme backbone could be
fitted to previously determined crystal structures with r.m.s.d.
values of 0.27–0.53 and 0.39–0.61 A˚ for all backbone atoms of
the closed and open monomers, respectively. Addition of the
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inhibitor to the crystal of the open/closed form thus did not
result in the closure of the open monomer. Such large-scale
rearrangement has been observed previously in the case of
Aeromonas caviae PREP. In that case, addition of benzyloxy-
research papers
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Figure 3
Molecular dynamics-derived structures of the ApAAP–L1 and ApAAP–L2 complexes. (a) B factors of backbone atoms derived from the 100–200 ns
time span of the MD simulations for the enzyme (propeller domain, green; hydrolase domain, cyan and blue; ligand, magenta and purple; residues
labelled according to Schechter & Berger, 1967). (b) Clustering of the substrate conformations in the cases of ApAAP–L1 (top) and ApAAP–L2
(bottom). (c) The superimposed complexes shown as the molecular surface of ApAAP, with substrates bound in the spacious inner cavity below the
propeller channel (cross-section; the propeller domain is shown in green, the hydrolase domain in cyan and the L1 and L2 substrates in magenta and
purple, respectively). (d, e) Close-up of the substrate-binding cavity. P1 Phe of L1 (d) is immersed in the specificity pocket, while P2 Leu and P40 Phe are
docked into hydrophobic pockets formed by both domains. The P40 Arg residue of L2 (e) pulls away from the hydrophobic surface towards the propeller
channel. Catalytic residues of AAP are labelled in italics.
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carbonyl-prolyl-prolinal (zPP) to a crystal consisting of open
monomers of PREP resulted in the closure of the enzyme in
the crystalline state, coupled to the shortening of one of the
unit-cell axes. The authors argued that the loose packing and
the spacious channel systems of that particular crystal form
allowed such grand rearrangements (Li et al., 2010). In the
case of the PREP crystals, the direction of domain motion is
nearly parallel to one of the unit-cell axes, allowing concerted
movement of layers of domains within the crystal. In contrast,
in ApAAP there are two different directions for potential
domain closure of the open monomers, neither of which is
parallel to a cell axis. Moreover, the closed monomers
between the open monomers obstruct concerted movement
of the latter, creating a more formidable restriction to such
movement (Supplementary Fig. S2).
Since the overall structures of the ApAAP molecules in the
newly determined ApAAP–CMK complexes highly resemble
those of previously determined unligated and noncovalent
inhibitor-bound states for both of these two crystal forms, our
findings support the two-state model of ApAAP with only two
possible relative domain orientations. In the case of A. caviae
PREP, various extents of opening were found in different
ligation states (Li et al., 2010), which is not the case here. In
ApAAP crystals (obtained in four different space groups
across a pH range of 4.6–8.0 in unligated
and ligated states with wild-type and
mutant sequences), monomers with
closed and open conformations can be
fitted with a backbone r.m.s.d. not
exceeding 0.68 and 1.18 A˚, respectively.
In the closed state the catalytic appa-
ratus is in the active conformation in all
cases, while in all of the open states the
catalytic apparatus is disassembled and
the loop holding the catalytic histidine is
highly flexible.
3.1.2. Binding of CMK inhibitor in
the crystal structures. The CMK mole-
cules are clearly shown in the electron-
density maps bound at the substrate-
binding sites of the AAP molecules
(Fig. 2). Interestingly, they are bound
only in the closed enzyme structures (in
all monomers in the closed/closed
crystal form and in only half of the
monomers in the open/closed crystal
form; Figs. 2b, 2d and 2e). It is clear
from the electron density that a
chemical reaction has occurred between
the closed AAP monomers and CMK:
the inhibitor is covalently bound to the
catalytic serine and histidine (Figs. 2b
and 2d). The P1 phenylalanine side
chain of the inhibitor is bound in the S1
pocket (the nomenclature of Schechter
& Berger, 1967 is used throughout the
text). However, the P2–P3 glycyl-
glycine moiety is less well defined by electron density,
suggesting looser binding of this part of the inhibitor, while the
benzyloxycarbonyl moiety is disordered, with the conforma-
tion and position of the P3 glycine being somewhat different
in the four ApAAP–CMK monomer structures (Fig. 2f). The
reason for this flexibility/disorder may be that neither S3–P3
contacts that orient its backbone nor side-chain-accom-
modating contacts exist for the small P3 glycine residue.
Comparing the four forms of CMK ligation with that of
enzyme–product complexes reveals that the accommodation
and the position of the P1–P2 moiety is similar, as expected,
showing conserved hydrogen bonds to the oxyanion site and
Arg526 (Fig. 2f).
Observing the inhibitor molecules in the closed monomers
of the open/closed crystal form proves that the inhibitor can
reach the active site of closed monomers of ApAAP by
diffusion within the crystal and that the enzyme is active in the
crystalline state. Interestingly, the inhibitor molecule did not
bind to the open monomers. As the active sites of the open
monomers are solvent-exposed in the crystal, the reason for
this cannot be the limited access to the active site but must be
the conformational differences affecting the substrate affinity
and catalytic efficiency: the disassembled state of the catalytic
triad, the large shift and destabilization of the loop containing
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Table 2
Accommodation of CMK (PDB entry 4re5, chain A) and substrate peptides L1 and L2 (molecular-
dynamics simulations) by ApAAP.
Residue positions of the CMK inhibitor and substrates are also labelled according to Schechter & Berger
(1967). Contacting residues (atoms within 4.5 A˚ distance) for each residue position of CMK and the








P4 CMK — —
L1 Glu Ala557
L2 — —
P3 CMK Gly —
L1 Ala Pro370, Phe371, Ala372, Phe488
L2 — —
P2 CMK Gly Arg526, Phe485, Phe488
L1 Leu Arg526, Phe153, Phe155, Phe169, Phe485, Phe488
L2 Gly Arg526, P10 or P50, P1, Phe153, Phe155, Phe485
P1 CMK Phe Gly369, Tyr446, Val471, Trp474, Met477, Leu482, Phe485,
Phe488, Ile489
L1 Phe Gly369, Tyr446, Val471, Trp474, Met477, Leu482, Phe485,
Phe488, Ile489
L2 Phe Gly369, P2, Tyr446, Val471, Trp474, Met477, Leu482, Phe485,
Phe488, Ile489, His556
P10 CMK — —
L1 Gln Ala372
L2 Glu —
P20 CMK — —
L1 Gly Tyr444
L2 Pro Ile558, Phe381, Tyr444, Ile558
P30 CMK — —
L1 Pro P40 , Phe381, Tyr444, Ile567, Ile558
L2 Phe —
P40 CMK — —
L1 Phe Ile20, Phe381, Ala564, Leu568
L2 Arg Ser66
P50 CMK — —
L1 Ala —
L2 Ala P2, Arg526, Leu115, Phe153, Phe155
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His556, the shift of the Asp524–Arg526 region and the small
changes in the S1 pocket.
3.2. Molecular-dynamics studies
3.2.1. Binding of substrates. MD simulations were carried
out involving the binding of two known substrates of ApAAP
to the enzyme: one of nine amino acids in length (sequence
EALFQGPFA; from here on referred to as L1) and another of
seven amino acids in length (sequence GFEPFRA; from here
on referred to as L2). ApAAP cleaves the peptide bond of its
oligopeptide substrates following phenylalanine residues (and,
with significantly less activity, leucine residues). In the case of
L1 the primary cleavage site is at Phe4, while L2 is cleaved
after Phe2 (Kiss et al., 2007).
L1 and L2 were placed into the ligand-binding pocket of a
closed ApAAPmonomer with the P1 residues of their primary
cleavage site overlaying that of the CMK inhibitor in the
crystal structure. An MCMM search was then applied to dock
substrates into the enzyme interior, followed by a 200 ns MD
simulation of the derived complexes. The final results showed
substrates bound in the spacious cavity between the domains
without disturbing the structure of the closed form of the
enzyme (Fig. 3): the backbone of the closed ApAAPmonomer
in the crystal structures (four copies; two in PDB entry 4re5
and two in PDB entry 4re6) and those of the simulation-
derived complexes could be fitted with r.m.s.d. values ranging
from 1.1 to 1.2 A˚. Two conserved hydrogen bonds to the
oxyanion pocket and a tailored hydrophobic pocket for the P1
side chain were able to direct and stabilize substrates in
an ideal position for cleavage (with distances between the
Ser445 O atom and the carbonyl C atom of the substrate P1
residue of 3.4 0.2 and 3.3 0.2 A˚ in the case of ApAAP–L1
and ApAAP–L2, respectively) without applying constraints
during the MD simulations. This is also well reflected in the
backbone B factors calculated for the substrates (Fig. 3a). The
P2–P10 segment shows characteristically low B-factor values,
with the P1 backbone being most restrained, indicating its
specific and strong coordination by the enzyme; while the
chain ends were quite mobile in the simulations, the P1 Phe
residue of both substrates was found to be most ordered. The
backbones of the P2–P10 segments of L1 and L2 run quite
similarly, but the remaining segments were found to be
accommodated in diverse ways (Figs. 3b, 3d and 3e). The
carbonyl O atoms of the P2 residue of both substrates form
a conserved hydrogen bond to Arg526. Additionally, the Phe
side chain of P2 of L1 docks into a spacious hydrophobic
crevice created by Phe153, Phe155 and Phe169 of the
propeller, Phe485 and Phe488 of the hydrolase domain and
the P1 residue. The Gly residue of L2 in the same position, the
N-terminus of this substrate, forms NH3
+  O-type intramole-
cular hydrogen bonds mainly to the P10 residue (in 84% of the
snapshots of the last 100 ns of the MD simulation) or the
C-terminus (in 3%). The carbonyl O atom of the P1 phenyl-
alanine of both substrates is bound by two hydrogen bonds to
the oxyanion hole (backbone amides of Gly369 and Tyr446)
while immersing into the hydrophobic S1 pocket lined by the
residues of the hydrolase domain (Pro370, Tyr446, Trp474,
Met477, Phe485, Phe488 and Ile489). P20 Pro of L2 is hosted
by Phe381, Ile558 and Tyr444. The carbonyl O atom of P30 of
L1 is stabilized by a main-chain hydrogen bond to Ile558; its
Pro side chain, while surrounded by hydrophobic amino acids
of the hydrolase domain (Phe381, Tyr444, Ile558 and Ile567),
forms a stacking interaction with Tyr444 (contacting AAP
residues for L1 and L2 binding in comparison with those of
CMK are listed in Table 2.).
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Figure 4
Domain motion of ApAAP complexes during MD simulation. (a) Backbone r.m.s.d. values (compared with the starting conformation) along the
trajectory of the MD simulation of the ApAAP–L1 (grey) and ApAAP–L2 (black) complexes. (b) The most significant motion of ApAAP–L2 in the last
100 ns of its MD simulation as derived by principal component analysis. The movement is shown in ten stages coloured from green to yellow. The black
dot indicates the position of the hinge region and the black arrow indicates the site of the greatest opening.
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3.2.2. Small-scale opening of the enzyme structure. As is
apparent in the backbone r.m.s.d. graph of the simulations
(Fig. 3a), after approximately 100 ns the complex formed with
L2 started to oscillate between different states. While clus-
tering of the conformers of the complex formed with L1
belonging to the 100–200 ns time span resulted in two quite
similar clusters, 47 clusters were found in case of ApAAP–L2,
which could be separated into three characteristically different
groups based on their backbone values: two minor populations
with high and low r.m.s.d. (15 and 8% of all conformers,
respectively) and a major group with intermediate values
(77% of all conformers).
Average structures of the groups were calculated and
compared. In case of the minor groups we found that while the
domains individually are very similar (the backbone of the
propeller domains could be fitted with an r.m.s.d. of 0.4 A˚ and
that of the hydrolase domains with an r.m.s.d. of 0.3 A˚), the fit
of the backbone atoms of the hydrolase domain increased by
nearly a factor of three (to 1.1 A˚ with the propeller domains
overlaid), demonstrating that it is not the inner structure of
the domains that is different in the two groups but their
respective orientation. Within the hydrolase domain, the
greatest change is observed at residues 503–562 (r.m.s.d. of
1.7 A˚), while the hinge region connecting the two domains
stays less disturbed. Comparing the calculated backbone B
factors of ApAAP–L1 and ApAAP–L2 (Fig. 4a), the greatest
difference was found in the flexibility of residues 82–89, a loop
of the propeller pointing toward the hydrolase domain, and
two loops of the hydrolase domain facing it: residues 522–525
(members of the loop carrying the catalytic Asp524) and
residues 552–562 (the loop with the catalytic His556 residue).
These regions are those that are most destabilized by the
opening of the structure (Harmat et al., 2011), supporting the
notion that it is a small-scale opening and closing that takes
place in the second half of the simulation of ApAAP-L2.
Principal component analysis also showed that the largest
amplitude motion of the 100–200 ns segment of the simulation
is a clamshell-like opening of the structure (Fig. 4b).
The fact that we only observed such motion in the simula-
tion of the complex formed with L2 could be rationalized by
the different binding modes of the two substrates. Both the P2
and P40 residues of L1 bind to hydrophobic pockets formed
by the domain interfaces, lined on one side by residues of
the propeller and on the other by residues of the hydrolase
domain. Thus, by filling the void between the two domains the
P2 Leu and P40 Phe of L1 reinforce the interlocking of the
clamshell-like structure. These interactions also place the
carboxy-terminus of L1 within hydrogen-bonding distance of
Lys24 of the propeller, and since the other part of the
substrate is rooted in the hydrolase domain, this also has a
domain movement-restricting effect. L2 has a Gly at the P2
position and an Arg at P40, neither of which can perform the
hydrophobic linker function: the end of the chain dislocates
into the space below the propeller channel. Being associated
chiefly with the hydrolase domain, a slight opening does not
influence the accommodation of L2; thus, its presence does not
hinder domain movements as much.
4. Discussion
ApAAP, just like its mammalian orthologue, functions both as
an exopeptidase and an endopeptidase. Its substrate-selection
mechanism involves the opening of the enzyme, in which the
propeller lid moves in a clamshell-like fashion: it is fixed on
the hinge side by interconnecting segments while opening by
a considerable extent (10–15 A˚) on the other side. The parts
travelling furthest from their closed conformation are loop-
(43–46) and loop-(83–88) of the propeller domain and loop-
(521–529) and loop-(551–560) of the hydrolase domain, which
are connected by numerous interdomain hydrogen bonds and
thus form the buckle region of the closed form. Incidentally,
these two surface-close loops of the hydrolase domain are
those carrying the His and Asp residues of the catalytic triad.
These loops lose their interdomain interactions as the opening
takes place, and as a consequence the His-loop becomes
flexible (with the side chain of His itself disappearing from
the electron-density map) and the Asp-loop restructures, thus
disassembling the catalytic triad (as indicated by the spreading
pegs representing the triad residues in Fig. 5). However,
previous studies were not able to distinguish whether it is the
binding of the substrate or the closure
of the enzyme that assembles the cata-
lytic triad.
In this study, two crystal structures of
an inhibitor-bound form of ApAAP
have been determined. Co-crystal-
lization of ApAAP with the CMK
inhibitor led to the formation of closed/
closed dimers, even if the crystallization
conditions of the previously obtained
open/closed dimers were adhered to. In
this structure the covalently bound
inhibitor is present in both monomers of
the dimers (Fig. 5b).
Addition of the CMK inhibitor to the
pre-formed crystal lattice of open/
closed dimers resulted in the formation
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Figure 5
Schematic view of the dimers of ApAAP discussed in this paper. (a) The asymmetric unligated
open/closed dimer of ApAAP. (b) The inhibitor-bound closed/closed dimer formed by co-
crystallization. (c) The open/closed dimer formed when the inhibitor was added to crystals of
asymmetric dimers.
electronic reprint
of asymmetric dimers composed of one closed monomer with
the inhibitor covalently linked to the catalytic Ser and His
residues and an open, unligated monomer (Fig. 5c). Here,
remarkably, the inhibitor migrated to the active site and
formed two covalent bonds to two amino acids of the catalytic
triad within the rigid frame of the crystal lattice. The monomer
units making up this crystal lattice thus represent opposite
ends of the catalytic cycle: an open, scavenger conformer with
a deactivated active site and a substrate-bound, closed
conformer. The appearance of both in the same crystal lattice
demonstrates that these forms co-exist under identical
experimental conditions, and supports the notion that the
native state of the enzyme is best described as a dynamic
equilibrium between open and closed states. Since the open or
closed nature of the adjoining monomer did not have an effect
on the conformation of the substrate-bound closed form, the
results also show that the monomer units function indepen-
dently (without signs of allostery), so that ligand binding and
catalysis at one site does not require the same at the other.
The overall binding mode of the CMK ligand and the
accommodation of its P1–P2 Gly-Phe moiety in the open/
closed structure is similar to that seen in case of the closed/
closed dimer, but a 0.92–1.79 A˚ r.m.s.d. of inhibitor-atom
positions within the overlaid protein matrices indicates subtle
differences (Fig. 2). The protein matrix of the closed monomer
itself is remarkably similar in both cases, with a backbone
r.m.s.d. of 0.27–0.56 A˚; therefore, it is not the alteration of the
binding site that causes the variation of CMK binding, rather it
is the conformational freedom of the binding process. This
short ligand has no side chains in its P2 and P3 positions (both
glycines) that would be able to form specific interactions with
the host protein matrix.
The fact that the backbone structure of the closed monomer
remained the same in the presence of the inhibitor also indi-
cates that the rigid structure of the closed form must be
penetrable to small ligands. Several different access routes
have been proposed that could be used by ligands to reach the
active site of the closed form of various oligopeptidases. The
channel piercing through the propeller domain was initially
suggested as the entrance, being the only opening on the
surface of PREP, the first enzyme in the family for which a
structure was determined. The propeller domain is the struc-
turally more variable of the two, resulting in an array of
different sized channels that even differ within orthologues
and might help to explain their differing substrate profiles
(Kaushik & Sowdhamini, 2011). Also, the modest widening of
this channel does not require backbone rearrangement; it can
be achieved by reorientation of the side chains clogging its
interior (Kaushik & Sowdhamini, 2011). Dynamic restruc-
turing of the backbone segments is needed in the case of the
other proposed admittance mechanisms. It has recently been
shown that another gate might open by the flip of a 20-amino-
acid, loosely structured loop in PREP (loopA formed by
residues 189–209) at the domain interface (St-Pierre et al.,
2011; Kaszuba et al., 2012). Another short helical segment that
belongs sequentially to the propeller domain, but runs along
the hydrolase domain and effects interdomain communication
(Papaleo et al., 2012), might also shift and expose yet another
tunnel towards the active site (Papaleo & Renzetti, 2012).
On the surface of the closed form of the ApAAP structure,
three narrow channels can be observed that connect to the
buried active site (Supplementary Fig. S3). In place of the long
loopA of PREP, a much shorter loop can be found (residues
130–133) that would leave this accession route ungated.
However, in the crystal structures of ApAAP an interdomain
hydrogen-bonded network of Asp482 (hydrolase domain)–
Arg113 (propeller domain)–Glu88 (conserved residue of
the propeller)–Arg526 (conserved residue of the hydrolase
domain) can be found which blocks the entrance under the
shortened loopA at the protein surface (Supplementary Fig.
S4a). In contrast, in PREP the corresponding residues are
Thr590, Lys172, Asp149 and Arg643, of which only Asp149
and Arg643 form hydrogen-bond associations and the other
two are not stabilized by a hydrogen-bond network; therefore,
if loopA fluctuates to an open position a wide entrance may
open up towards the interior (Supplementary Fig. S4b). The
channel that passes through this region of ApAAP is directly
accessible from the solvent owing to the shortness of loopA,
but has a bottleneck radius of 0.7 A˚ owing to the hydrogen-
bonded network of the aforementioned quartet. Another,
wider side entrance by the loop carrying the catalytic His556
(His-loop) has a bottleneck radius of 1.1 A˚. In contrast, the
bottleneck radius of the propeller channel, a third possible
accession route, is 1.7 A˚, which thus provides a quite narrow,
but still the most unhindered, passage to the active site. Thus,
we propose that the most likely route of the inhibitor to the
active site of the closed monomer within the crystal is the
propeller channel.
It is also noteworthy that the inhibitor did not bind to the
open form, despite the considerable driving force of the
possibility of forming two covalent bonds. It has been shown
previously that the binding of covalent inhibitors is coupled to
the closure of oligopeptidases (Li et al., 2010). In that case,
crystals of the open form of PREP monomers were soaked
overnight in solution of an inhibitor, which led to the emer-
gence of a crystal with a ligand bound to the active site and the
closure of all monomers. This result, however, still has not
clarified whether the active site can be ordered to form a
catalytically active conformation in the absence of the
propeller domain just by the binding of a substrate or whether
the closure of the enzyme is required for re-activation of the
active site. (To state it another way: whether the closure of the
enzyme is a consequence or a condition of the chemical
reaction with the ligand.) Our densely packed crystals of the
open/closed dimers of ApAAP did not allow such a global
rearrangement as seen in the case of PREP (Li et al., 2010).
Since the molecules of the inhibitor were able to reach the
active site of the closed monomer within the crystal lattice,
there is no reason why they should not have reached the
clearly more accessible active site of the open form. The fact
that the chemical reaction did not take place shows, for the
first time, that the open form is indeed catalytically disabled
and that closure of the enzyme is required for catalytic
activity.
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In order to study the binding of longer substrates to
ApAAP, MD simulations were carried out for the binary
complexes of ApAAP formed with two of its known peptide
substrates (Kiss et al., 2007; Fig. 3, Table 2). The inner cavity
of the closed monomer proved to be amply spacious for
accommodating either peptide without disturbing the overall
structure. Even though in the fully solvated state the channels
leading to the enzyme interior did widen (with bottleneck radii
of 2.0 A˚ for the propeller channel, 1.2 A˚ for the side entrance
near the His-loop and 0.9 A˚ under loopA), the propeller
channel remained the most spacious entrance route to the
active site. A force-biased MD study of PREP has demon-
strated that small substrates (Z-Pro-prolinal in this case) can
be pulled through the propeller channel, but only with the
application of an extremely high force (St-Pierre et al., 2011).
The propeller channel of ApAAP is wider than that of PREP
and thus might be more suitable for allowing small ligands
to reach the active site, but it is highly unlikely that longer
oligopeptide substrates would be able to utilize this pathway;
therefore, we postulate that longer and more structured
ligands might reach the active site assisted by the opening
of the structure. Simulations also showed that opening and
closing is a trait of ApAAP that is not lost even when peptide
ligands are bound within the ligand-binding cavity, indicating
that after catalytic cleavage, the dissociated products, if too
large for the propeller channel, might leave the enzyme
interior by the unhindered route provided by the opening.
Similar opening and closing domain movements of an
oligopeptidase have recently been observed in MD simula-
tions of PREP monomers, prompting the authors to also
propose this motion as the major substrate-admittance/release
mechanism of that enzyme. In their model, both the opening
and closing of the enzyme is prompted by the presence of the
substrate (Kaushik et al., 2014). This mechanism might be
modulated by the flexible loops (loopA, for example) near
the domain interface that also appear to have limited size-
regulation function (Szeltner et al., 2013). Our results indicate
that in the case of ApAAP the presence of a ligand is not
necessary to ignite domain movements; rather, it is the
dynamic equilibrium mixture of the open and closed states
that the ligands encounter and may attempt to interact with.
Whether this mixture is dominated by one form or another
might be fine-tuned by the amino-acid composition of the
domain interfaces.
Besides that of ApAAP, the crystal structures of the open
forms of further oligopeptidases have been determined: those
of PREP from lower taxa (Shan et al., 2005; Li et al., 2010) and
oligopeptidase B (McLuskey et al., 2010; Canning et al., 2013).
Thus, clarifying the molecular details involved in the opening
and closing of AAP has a universal appeal, while also allowing
a better understanding of such a physiologically relevant
enzyme. There are two structural models presently available
for the study of AAP: PhAAP with a permanent side entrance
(Menyha´rd et al., 2013) and the flexible ApAAP that utilizes
domain movements for substrate selection (Harmat et al.,
2011). PhAAP is a hexamer in its active form, the structure of
which is of a complex self-compartmentalized inner channel-
and-chamber system where only suitably short and unstruc-
tured ligands are able to reach the side entrance and, through
it, the active site of its monomers. As the tetrameric active
form of mammalian AAP might not provide enough building
blocks for such an intricate system as observed in the case of
PhAAP, we suggest that it consists of ApAAP-like flexible
monomers and also resorts to an opening–closing mechanism
for substrate screening.
5. Conclusion
In this paper, crystallography was used as a tool for the
sequential sampling of the favourable conformations of a
substrate-binding process. Firstly, we established that adding a
substrate-like inhibitor to a solution of ApAAP results in the
formation of closed/closed ligand-bound dimers. The fact that
an open/closed asymmetric dimer of the unligated form of
ApAAP could also be crystallized under very similar experi-
mental conditions in the absence of the ligand adds additional
support to a model in which an equilibrium mixture of the
open and closed forms must be present in the solution of the
resting state of the enzyme: this equilibrium is shifted towards
the closed form in the presence of the ligand. The final
sampling step was carried out by the inhibitor itself, which,
when added to the rigid mixture of these two states in the
crystal, chose only one of them, the closed conformer, for
binding. This way, we were able to capture both the unligated
and the substrate-bound form of the enzyme within the same
crystal lattice, i.e. two catalytically distinct states. Catalysis
itself can only take place if the enzyme assumes its active
conformation by transferring from an open, scavenger state to
its activated, closed form.
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